SE440772B - Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat - Google Patents

Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat

Info

Publication number
SE440772B
SE440772B SE7704478A SE7704478A SE440772B SE 440772 B SE440772 B SE 440772B SE 7704478 A SE7704478 A SE 7704478A SE 7704478 A SE7704478 A SE 7704478A SE 440772 B SE440772 B SE 440772B
Authority
SE
Sweden
Prior art keywords
naphylmethyl
cinnamyl
procedure
amine derivatives
preparing new
Prior art date
Application number
SE7704478A
Other languages
English (en)
Swedish (sv)
Other versions
SE7704478L (sv
Inventor
D Berney
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH533576A external-priority patent/CH620896A5/de
Priority claimed from CH1618276A external-priority patent/CH625202A5/de
Priority claimed from CH92177A external-priority patent/CH625779A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7704478L publication Critical patent/SE7704478L/
Publication of SE440772B publication Critical patent/SE440772B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7704478A 1976-04-28 1977-04-19 Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat SE440772B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH533576A CH620896A5 (en) 1976-04-28 1976-04-28 Process for the preparation of novel N-(3-phenyl-2-propenyl)naphthylmethylamines
CH1618276A CH625202A5 (en) 1976-12-22 1976-12-22 Process for the preparation of novel N-(1-naphthylmethyl)-amines
CH92077 1977-01-26
CH92177A CH625779A5 (en) 1977-01-26 1977-01-26 Process for the preparation of N-(3-phenyl-2-propenyl)naphthylmethylamines

Publications (2)

Publication Number Publication Date
SE7704478L SE7704478L (sv) 1977-10-29
SE440772B true SE440772B (sv) 1985-08-19

Family

ID=27428030

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704478A SE440772B (sv) 1976-04-28 1977-04-19 Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat

Country Status (20)

Country Link
US (1) US4282251A (fr)
JP (1) JPS52131564A (fr)
AU (1) AU513249B2 (fr)
CA (1) CA1092158A (fr)
CY (1) CY1238A (fr)
DE (1) DE2716943C2 (fr)
DK (1) DK147068C (fr)
FI (1) FI65058C (fr)
FR (1) FR2349566A1 (fr)
GB (2) GB1579878A (fr)
HK (1) HK71884A (fr)
IE (1) IE45727B1 (fr)
IL (1) IL51945A (fr)
MY (1) MY8400059A (fr)
NL (1) NL187349C (fr)
NZ (1) NZ183933A (fr)
PH (1) PH16489A (fr)
PT (1) PT66475B (fr)
SE (1) SE440772B (fr)
SG (1) SG19484G (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000896B1 (fr) * 1977-08-19 1982-10-13 Sandoz Ag Propényl-amines, procédés pour leur préparation et les compositions pharmaceutiques les contenant
DE3069633D1 (en) * 1979-08-22 1984-12-20 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
CH648030A5 (de) * 1980-12-15 1985-02-28 Sandoz Ag Benzopyran-allylaminderivate, verfahren zu ihrer herstellung und ihre verwendung.
US5250546A (en) * 1984-09-28 1993-10-05 Nippon Chemiphar Co., Ltd. Amino-alcohol derivatives and processes for their preparation
JPS61112811A (ja) * 1984-11-06 1986-05-30 渡辺 宏明 ゆるみ止め付ネジ
DE3582060D1 (de) * 1984-11-22 1991-04-11 Sandoz Ag Homopropargylamine.
US5030625A (en) * 1984-11-22 1991-07-09 Sandoz Ltd. Anti-fungal homopropargylamine compounds
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
DE3902509A1 (de) * 1989-01-28 1990-08-09 Basf Ag Fungizide mischung
US5017723A (en) * 1990-02-26 1991-05-21 Jouveinal S.A. Substituted ethylamines, their preparation process, their use as medicine and their synthesising agents
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9513750D0 (en) * 1995-07-06 1995-09-06 Sandoz Ltd Use of allylamines
US6075056A (en) * 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
JP4029960B2 (ja) 2001-10-05 2008-01-09 独立行政法人理化学研究所 アブシジン酸生合成阻害剤
WO2004080945A1 (fr) * 2003-03-12 2004-09-23 Natco Pharma Limited Procede de preparation de n-methyl-1-naphthalenemethanamine
US20080176908A1 (en) * 2007-01-18 2008-07-24 Mcanally Weylan R Method of using squalene monooxygenase inhibitors to treat acne
RU2539654C1 (ru) * 2013-11-06 2015-01-20 Ринат Нажибуллович Шахмаев Способ получения нафтифина
CN103664631B (zh) * 2013-12-20 2015-07-01 西北师范大学 一种盐酸萘替芬的制备方法
CN104055756B (zh) * 2014-05-07 2016-10-05 中国科学院上海药物研究所 盐酸萘替芬的衍生物、制备方法及用途
CN108164423B (zh) * 2017-12-27 2021-07-13 福建金山准点制药有限公司 一种盐酸萘替芬的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2601275A (en) * 1949-10-29 1952-06-24 Givaudan Corp Aromatic chlorethylamines and their salts
US2609392A (en) * 1950-04-27 1952-09-02 Sharp & Dohme Inc Cinnamyl quaternary ammonium compounds
US3094561A (en) * 1959-06-04 1963-06-18 Sahyun Halocinnamyl quaternary ammonium compounds
US3366688A (en) * 1962-10-22 1968-01-30 Lilly Co Eli Process for the preparation of alpha, alpha-disubstituted-gema-hydroxyamines
DE1768500A1 (de) * 1968-05-18 1972-01-05 Degussa Verfahren zur Herstellung von Alkoxygruppen enthaltenden Aminoketonen II

Also Published As

Publication number Publication date
GB1579878A (en) 1980-11-26
JPS52131564A (en) 1977-11-04
IL51945A0 (en) 1977-06-30
CY1238A (en) 1984-06-29
DE2716943A1 (de) 1977-11-17
FR2349566A1 (fr) 1977-11-25
HK71884A (en) 1984-09-28
FI65058B (fi) 1983-11-30
IE45727L (en) 1977-10-28
FI65058C (fi) 1984-03-12
NL187349B (nl) 1991-04-02
IE45727B1 (en) 1982-11-17
IL51945A (en) 1981-06-29
FR2349566B1 (fr) 1980-01-18
PT66475B (fr) 1978-12-14
NL187349C (nl) 1991-09-02
DK171577A (da) 1977-10-29
NL7704401A (nl) 1977-11-01
PT66475A (fr) 1977-05-01
AU2459177A (en) 1978-11-02
JPS6149297B2 (fr) 1986-10-29
MY8400059A (en) 1984-12-31
CA1092158A (fr) 1980-12-23
AU513249B2 (en) 1980-11-20
FI771242A (fr) 1977-10-29
DK147068C (da) 1984-09-10
NZ183933A (en) 1979-11-01
DK147068B (da) 1984-04-02
SE7704478L (sv) 1977-10-29
US4282251A (en) 1981-08-04
SG19484G (en) 1985-01-04
PH16489A (en) 1983-10-28
DE2716943C2 (de) 1986-08-14
GB1579879A (en) 1980-11-26

Similar Documents

Publication Publication Date Title
SE442400B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-alkylenaminopropaner
SE430601B (sv) Analogiforfarande for framstellning av nya dipeptidderivat
SE446740B (sv) Forfarande for framstellning av muramyldipeptidderivat
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
FI772915A (fi) Foerfarande foer framstaellning av nya antracyklinantibiotika
SE7704545L (sv) Forfarande for framstellning av nya adeninderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE436566B (sv) Analogiforfarande for framstellning av nya fenetylaminderivat
SE424553B (sv) Forfarande for framstellning av nya indazol-derivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE440903B (sv) Forfarande for framstellning av nya 1-aryloxi-2-hydroxi-3-aminopropaner
SE7703634L (sv) Forfarande for framstellning av nya amidinopenicillanoyloxialkylamoxicillinater
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7704478-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7704478-2

Format of ref document f/p: F